SOLV — Solventum Corp. · P/E 9.1, rev $8.32B

Solventum Corp. (SOLV) is a medical instruments & supplies company listed on NYSE.

Latest reported SOLV revenue for 2025-12-31 was $8.32B. Net income was $1.56B. Revenue was up 0.9% from 2024-12-31 to 2025-12-31. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.

Use this SOLV page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SOLV quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SOLV SEC filings page. Lician reads the product cache first so this HTML stays unique to Solventum Corp. even when a live quote feed is slow.